Skip to main content
publicaciones

Scientific articles published by the researchers of Barcelonaβeta Brain Research Center (BBRC), related to Alzheimer's disease, neuroimaging, memory and neurodegenerative diseases, among other fields.

Julvez, J., Paus, T., Bellinger, D., Eskenazi, B., Tiemeier, H., Pearce, N., Ritz, B., White, T., Ramchandani, P., Gispert, J. D., Desrivieres, S., Brouwer, R., Boucher, O., Alemany, S., Lopez-Vicente, M., Suades-Gonzalez, E., Forns, J., Grandjean, P., & Sunyer, J. (2016). Environment and Brain Development: Challenges in the Global Context. Neuroepidemiology, 46, 79-82

Molinuevo J.L., Gispert, J.D., Gramunt, N., Fauria, K., Esteller, M., Minguillon, C., Sánchez-Benavides, G., Huesa, G., Morán, S. and Camí, J. The ALFA project: a research platform to identify early pathophysiological features of Alzheimer’s disease. Alzheimers Dement., 2, 82-92

Molinuevo, J. L., Cami, J., Carne, X., Carrillo, M. C., Georges, J., Isaac, M. B., Khachaturian, Z., Kim, S. Y. H., Morris, J. C., Pasquier, F., Ritchie, C., Sperling, R., & Karlawish, J. (2016). Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit. Alzheimers & Dementia, 12, 614-622

Padayachee ER, Zetterberg H, Portelius E, Borén J, Molinuevo JL, Andreasen N, Cukalevski R, Linse S, Blennow K, Andreasson U. Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele. Brain Res. 2016 Nov 15;1651:11-16

Ritchie, C. W., Molinuevo, J. L., Truyen, L., Satlin, A., Van der Geyten, S., Lovestone, S., & European Prevention, A. s. (2016). Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project. Lancet Psychiatry, 3, 179-186

Rojas, S., Herance, J. R., Gispert, J. D., Arias, B., Miquel, I., Lopez, R., Sanchez, P., Rincon, E., & Murat, J. . Characterization of the Biodistribution and Systemic Absorption of TT-173, a New Hemostatic Agent of Recombinant Human Tissue Factor, Using Radiolabeling with 18F. Eur J Drug Metab Pharmacokinet, 2016

Sánchez-Benavides G, Peña-Casanova J, Casals-Coll M, Gramunt N, Manero RM, Puig-Pijoan A, Aguilar M, Robles A, Antúnez C, Frank-García A, Fernández-Martínez M, Blesa R; NEURONORMA Study Team. One-Year Reference Norms of Cognitive Change in Spanish Old Adults: Data from the NEURONORMA Sample. Arch Clin Neuropsychol. 2016 Jun;31(4):378-88. doi: 10.1093/arclin/acw018

Sanchez-Benavides, G., Gispert, J. D., Fauria, K., Molinuevo, J. L., & Gramunt, N. (2016). Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort. Alzheimers Dement (Amst), 4, 149-158

Shakeri M, Lombaert H, Datta AN, Oser N, Létourneau-Guillon L, Lapointe LV, Martin F, Malfait D, Tucholka A, Lippé S, Kadoury S; Alzheimer's Disease Neuroimaging Initiative. Statistical shape analysis of subcortical structures using spectral matching. Comput Med Imaging Graph. 2016 Sep;52:58-71. doi: 10.1016/j.compmedimag.2016.03.001

Suarez-Calvet, M., Kleinberger, G., Araque Caballero, M. A., Brendel, M., Rominger, A., Alcolea, D., Fortea, J., Lleo, A., Blesa, R., Gispert, J. D., Sanchez-Valle, R., Antonell, A., Rami, L., Molinuevo, J. L., Brosseron, F., M., & Haass, C., et al. (2016). sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol Med, 8, 466-476